Background: The *h/*y+B*57 genotype, which encodes high expression Killer Immunoglobulin-like Receptor (KIR)3DL1 variants and HLA-B*57 is the KIR/HLA combination with the strongest effect on slowing time to AIDS and controlling HIV viral load, as compared to Bw6 homozygotes (Bw6hmz). The interaction of 3DL1 with HLA-B*57 is a potent natural killer (NK) cell licensing combination. NK cell licensing plays a role in the potency of antibody dependent cellular cytotoxicity (ADCC) activity. The percentage of functional NK cells induced by HLAnull or autologous HIV-infected CD4 cells is higher when from *h/*y+B*57 carriers than from Bw6hmz or carriers of several other 3DL1hmz/HLA-Bw4 combinations. Using cells from HIV-infected slow progressors (SP) we investigated whether KIR3DL1/HLA genotypes that support licensing (3DL1+Bw4) generate NK cells with higher ADCC activity than those that do not (3DL1+Bw6hmz). Our hypothesis is that NK cells from HIV-infected SP mediate ADCC activity. Methodology: We studied 48 3DL1hmz SP with plasma viral loads <3000 cells/mm3, including HLA-Bw4+ HLA-B*57- (n=34), HLA-Bw6hmz (n=12) and *h/*y+B*57 (n=6) carriers. Anti-HIV ADCC was measured using a GranToxiLux (GTL) assay, which assesses the ability of NK cells (effectors) to deliver granzyme B (GzB) to HIV gp120-coated CEM.NKr.CCR5 targets (%GzB+ cells) in the presence of a common pooled source of anti-HIV immunoglobulin G. The significance of between group differences was assessed using the Mann-Whitney test. Results: NK cells from all HLA-Bw4+ and Bw6hmz 3DL1hmz mediated equivalent levels of ADCC (21.1 } 13.9 vs 24.05 } 20.7 %GrB cells+, p=0.87). NK cells from *h/*y+B*57 carriers also mediated similar levels of ADCC activity (20.7 } 16.1) as those from Bw6hmz (p=0.96) and carriers of other Bw4 alleles (21.1 } 13.8, p=0.85). Conclusions: NK cells from HIV infected SP mediate ADCC. Carrying KIR/HLA combinations, that play a role in NK cell licensing through KIR3DL1 ligation, does not influence the potency of ADCC activity of NK cells from HIV-infected SP. These results contrast with previous studies by us and others using NK cells from uninfected individuals, where KIR3DL1/HLA-B genotype does appear to influence levels of ADCC activity. Further investigation will be needed to determine whether HIV infection even in this well controlled SP population abrogates the influence of licensing on NK mediated ADCC activity.